These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 33558691)

  • 1. Treatment strategies for cryptococcal infection: challenges, advances and future outlook.
    Iyer KR; Revie NM; Fu C; Robbins N; Cowen LE
    Nat Rev Microbiol; 2021 Jul; 19(7):454-466. PubMed ID: 33558691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluconazole alters the polysaccharide capsule of Cryptococcus gattii and leads to distinct behaviors in murine Cryptococcosis.
    Santos JR; Holanda RA; Frases S; Bravim M; Araujo Gde S; Santos PC; Costa MC; Ribeiro MJ; Ferreira GF; Baltazar LM; Miranda AS; Oliveira DB; Santos CM; Fontes AC; Gouveia LF; Resende-Stoianoff MA; Abrahão JS; Teixeira AL; Paixão TA; Souza DG; Santos DA
    PLoS One; 2014; 9(11):e112669. PubMed ID: 25392951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cryptococcus neoformans, a global threat to human health.
    Zhao Y; Ye L; Zhao F; Zhang L; Lu Z; Chu T; Wang S; Liu Z; Sun Y; Chen M; Liao G; Ding C; Xu Y; Liao W; Wang L
    Infect Dis Poverty; 2023 Mar; 12(1):20. PubMed ID: 36932414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryptococcal therapies and drug targets: the old, the new and the promising.
    Coelho C; Casadevall A
    Cell Microbiol; 2016 Jun; 18(6):792-9. PubMed ID: 26990050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combatting the evolution of antifungal resistance in Cryptococcus neoformans.
    Bermas A; Geddes-McAlister J
    Mol Microbiol; 2020 Nov; 114(5):721-734. PubMed ID: 32697029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The sixth international conference on cryptococcus and cryptococcosis.
    Coenjaerts FE
    FEMS Yeast Res; 2006 Mar; 6(2):312-7. PubMed ID: 16487353
    [No Abstract]   [Full Text] [Related]  

  • 7. Screening of Natural Lead Molecules Against Putative Molecular Targets of Drug-resistant Cryptococcus spp: An Insight from Computer-aided Molecular Design.
    Manjunath M; Skariyachan S
    Curr Top Med Chem; 2018; 18(31):2681-2701. PubMed ID: 30659541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryptococcosis: epidemiology, fungal resistance, and new alternatives for treatment.
    Gullo FP; Rossi SA; Sardi Jde C; Teodoro VL; Mendes-Giannini MJ; Fusco-Almeida AM
    Eur J Clin Microbiol Infect Dis; 2013 Nov; 32(11):1377-91. PubMed ID: 24141976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of iron chelators on growth and expression of iron-related genes of Cryptococcus species.
    Chayakulkeeree M; Tangkoskul T; Waywa D; Tiengrim S; Pati N; Thamlikitkul V
    J Mycol Med; 2020 Apr; 30(1):100905. PubMed ID: 31706700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Mechanosensitive Channel Governs Lipid Flippase-Mediated Echinocandin Resistance in Cryptococcus neoformans.
    Cao C; Wang Y; Husain S; Soteropoulos P; Xue C
    mBio; 2019 Dec; 10(6):. PubMed ID: 31822582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiazole derivatives act on virulence factors of Cryptococcus spp.
    de Sá NP; de Barros PP; Junqueira JC; Vaz JA; de Oliveira RB; Rosa CA; Santos DA; Johann S
    Med Mycol; 2019 Jan; 57(1):84-91. PubMed ID: 29471408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental Evolution of Antifungal Resistance in Cryptococcus neoformans.
    Bermas A; Geddes-McAlister J
    Curr Protoc Microbiol; 2020 Dec; 59(1):e116. PubMed ID: 32986290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combating increased antifungal drug resistance in
    Deng H; Song J; Huang Y; Yang C; Zang X; Zhou Y; Li H; Dai B; Xue X
    Acta Biochim Biophys Sin (Shanghai); 2023 Feb; 55(4):540-547. PubMed ID: 36815374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward improved anti-cryptococcal drugs: Novel molecules and repurposed drugs.
    Krysan DJ
    Fungal Genet Biol; 2015 May; 78():93-8. PubMed ID: 25514636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adaptation to Fluconazole via Aneuploidy Enables Cross-Adaptation to Amphotericin B and Flucytosine in Cryptococcus neoformans.
    Yang F; Gritsenko V; Lu H; Zhen C; Gao L; Berman J; Jiang YY
    Microbiol Spectr; 2021 Oct; 9(2):e0072321. PubMed ID: 34585947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Antivirulence Approach for Preventing Cryptococcus neoformans from Crossing the Blood-Brain Barrier via Novel Natural Product Inhibitors of a Fungal Metalloprotease.
    Aaron PA; Vu K; Gelli A
    mBio; 2020 Jul; 11(4):. PubMed ID: 32694141
    [No Abstract]   [Full Text] [Related]  

  • 17. Virulence in Cryptococcus species.
    Ma H; May RC
    Adv Appl Microbiol; 2009; 67():131-90. PubMed ID: 19245939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative antifungal susceptibility analyses of Cryptococcus neoformans VNI and Cryptococcus gattii VGII from the Brazilian Amazon Region by the Etest, Vitek 2, and the Clinical and Laboratory Standards Institute broth microdilution methods.
    Nishikawa MM; Almeida-Paes R; Brito-Santos F; Nascimento CR; Fialho MM; Trilles L; Morales BP; da Silva SA; Santos W; Santos LO; Fortes ST; Cardarelli-Leite P; Lázera MDS
    Med Mycol; 2019 Oct; 57(7):864-873. PubMed ID: 30657975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Predicted Mannoprotein Participates in
    Reuwsaat JCV; Motta H; Garcia AWA; Vasconcelos CB; Marques BM; Oliveira NK; Rodrigues J; Ferrareze PAG; Frases S; Lopes W; Barcellos VA; Squizani ED; Horta JA; Schrank A; Rodrigues ML; Staats CC; Vainstein MH; Kmetzsch L
    mSphere; 2018 Apr; 3(2):. PubMed ID: 29897877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic and antagonistic drug interactions in the treatment of systemic fungal infections.
    Wambaugh MA; Denham ST; Ayala M; Brammer B; Stonhill MA; Brown JC
    Elife; 2020 May; 9():. PubMed ID: 32367801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.